SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-060244
Filing Date
2022-03-01
Accepted
2022-03-01 10:31:32
Documents
6
Effectiveness Date
2022-03-01

Document Format Files

Seq Description Document Type Size
1 S-8 d683320ds8.htm S-8 35782
2 EX-5.1 d683320dex51.htm EX-5.1 11440
3 EX-23.1 d683320dex231.htm EX-23.1 1673
4 EX-FILING FEES d683320dexfilingfees.htm EX-FILING FEES 21069
5 GRAPHIC g6833203.jpg GRAPHIC 10827
6 GRAPHIC g6833204.jpg GRAPHIC 9470
  Complete submission text file 0001193125-22-060244.txt   88423
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263134 | Film No.: 22694894
SIC: 2834 Pharmaceutical Preparations